Adult

AHAH: Urinary Tract Infections

Lower UTI (including suspected CA-UTI)

Consider catheter change under antimicrobial cover.

 

Duration: 3 days (female), 7 days (male or catheterised) 

Antibiotic Regimens:

Route

Antibiotic and Dosage

Notes

Oral (Preferred)


 

 


 

nitrofurantoin 50mg po QDS

Or Oxford Health will use nitrofurantoin M/R 100mg BD (not on formulary at OUH). See Nitrofurantoin MHRA drug safety updates 

cefalexin 500mg po BD

 

fosfomycin 3g po every 3 days

1 dose in female, 2 doses in males

co-trimoxazole 960mg po BD

Pause ACE inhibitors/Angiotensin receptor blockers or Potassium sparing diuretics 

Ideally reserve for more serious infections

pivmecillinam 400mg po STAT then 200mg po TDS

 

IV

gentamicin 5mg/kg iv STAT

1 dose is considered curative

See gentamicin monograph for dosing (including renal dosing)

Order of preference by eGFR (mL/min/1.73m2):

Upper UTI, Pyelonephritis or CA-UTI with systemic symptoms

Change catheter (if present) under antimicrobial cover.

 

Duration: 5-7 days

Antibiotic Regimens:

Route

Antibiotic and Dosage

Notes

Oral (Preferred)

cefalexin 1g po TDS

 

co-trimoxazole 960mg po BD

Pause ACE inhibitors/Angiotensin receptor blockers or Potassium sparing diuretics 

IV (Aim for rapid oral switch)

gentamicin 5mg/kg iv OD (gentamicin is for a maximum of 3 days).

Take a gentamicin level at 6-14 hours after first dose to calculate dosing interval, usually 24 hourly, 36 hourly or 48 hourly. See gentamicin monograph for dosing (including renal dosing) and monitoring

 

Pseudomonas lower UTI

Change catheter (if present) under antimicrobial cover.

 

Duration: 7 days

Antibiotic Regimens:

NB: Here IV therapy is usually preferred over ciprofloxacin. 

Route

Antibiotic and Dosage

Notes

Oral

ciprofloxacin 750mg po BD

See Fluoroquinolone antibiotics - severe adverse effects section for MHRA alert information

IV (Aim for rapid oral switch)

gentamicin 5mg/kg iv STAT

1 dose is considered curative

See gentamicin monograph for dosing (including renal dosing)

piperacillin-tazobactam Elastomeric (13.5g/24h)

Via OPAT

If no regimen is considered suitable, or there is a preference to avoid quinolones, consult the infection team.

Editorial Information

Last reviewed: 01 Jan 2025